In type 2 diabetes, some glucose-lowering drugs reduce HbA<sub>1c</sub> more than others; drugs do not differ for mortality.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 33197350.
- Also identified by DOI 10.7326/ACPJ202011170-053.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tsapas A, Avgerinos I, Karagiannis T, et al. <b>Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis.</b> Ann Intern Med. 2020;173:278-86. 32598218.
Medical subject headings
- Diabetes Mellitus, Type 2
- Pharmaceutical Preparations